U.S. District Judge Mark Pittman in Texas denied compounders' bid for a preliminary injunction, according to the court docket ...

April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...

GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Novo Nordisk has become aware of several hundred units of Ozempic® (semaglutide) injection 1 mg distributed outside the Novo ...

Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...

A doctor has shared some of the common reasons people taking weight loss jabs may notice hair loss, including those most likely to experience the side effect and how to combat it ...

Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 ...

Harvard Medical School experts reported that a rapid loss of fat in the face can cause a hollowed look to the face; changes ...

The MOU marks a significant step in strengthening the Kingdom’s healthcare sector and pharmaceutical manufacturing ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Ozempic, widely used for weight loss, is now linked to a surprising side effect—'Ozempic feet'—marked by foot fat loss, ...